Loading…
A novel synthetic compound, 3-amino-3-(4-fluoro-phenyl)-1H-quinoline-2,4-dione, inhibits cisplatin-induced hearing loss by the suppression of reactive oxygen species: In vitro and in vivo study
Highlights ► KR-22332 is a novel otoprotective synthetic compound against cisplatin-induced ototoxicity. ► KR-22332 protected auditory cells from cisplatin by blocking the change of MMP and ROS. ► KR-22332 inhibited the activation of MAPKs and inflammatory cytokines by cisplatin. ► Transtympanic adm...
Saved in:
Published in: | Neuroscience 2013-03, Vol.232, p.1-12 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Highlights ► KR-22332 is a novel otoprotective synthetic compound against cisplatin-induced ototoxicity. ► KR-22332 protected auditory cells from cisplatin by blocking the change of MMP and ROS. ► KR-22332 inhibited the activation of MAPKs and inflammatory cytokines by cisplatin. ► Transtympanic administration of KR-22332 in a rat model was protective against cisplatin-induced hearing loss. ► KR-22332 can be delivered topically through the middle ear, minimizing systemic effects. |
---|---|
ISSN: | 0306-4522 1873-7544 |
DOI: | 10.1016/j.neuroscience.2012.12.008 |